Corporate Overview

  GensKey Medicine is a company that specializes in providing molecular diagnostic solutions and testing services for infectious diseases. We offer a comprehensive, one-stop solution for high-throughput gene detection of pathogenic microorganisms, encompassing reagents, instrument,software, and related applications, with the aim to facilitate healthcare institutions in establishing precise diagnostic capabilities and monitoring systems for novel pathogens.

 The R&D Center of GensKey Medicine was founded in 2018 at the Changping Life Science Park in Beijing. Its international headquarters are based in Singapore, while its production facility is located at the Wuqing Startup Headquarters Base in Tianjin. The company operates fully-owned medical testing laboratories in Beijing, Shanghai, Guangzhou, and Tianjin, and has established experimental service delivery points across more than twenty provinces and municipalities in China. In particular, the Tianjin branch boasts an independent GMP-compliant manufacturing workshop, with a total area surpassing 19,000 square meters.

GensKey Medical has assembled a team of outstanding talents from multinational pharmaceutical enterprises, clinical diagnostic companies, and gene detection firms. Currently, 90% of the company's staff have backgrounds in life sciences and clinical medicine, with over 30% holding doctoral degrees and more than 50% possessing master's degrees.

Since 2019, GensKey Medical has successively attracted multiple well-known strategic investors including Legend Capital, SoftBank China Venture Capital, Fortune Capital, LGIMIC Venture Capital，Yuanju Capital, Huagai Capital, Yuanbio Venture Capital, Apricot Capital, CPE, Oriza Seed, Taikang, among others, bringing in several hundred million yuan in total financing.

GMP-certified facility
GensKey GMP Factory, is located in the Wuqing Development Zone of Tianjin, featuring a multi-story complex with an overall area exceeding 2000 square meters. The facility houses independent production workshops for medical device equipment, in vitro diagnostic reagents, and medical software. It has been certified to the ISO 13485:2016 quality management system standard, and currently, multiple NMPA Class II and Class III medical devices have successfully passed the National Medical Products Administration's system evaluations. The factory implements 360-degree comprehensive management and supervision across all production lines, encompassing raw material control, production management, quality inspection control, warehousing, and transportation, ensuring controllability and traceability throughout the product lifecycle.

The company currently holds certifications for over thirty products, ranging from Class I to Class III categories, which cover sample pretreatment reagents, nucleic acid extraction and purification reagents, sequencing reaction general-purpose reagents, sample pretreatment systems, fully automated nucleic acid extraction and purification instruments, high-throughput fully automated sample preparation systems, high-throughput sequencers, and pathogen bioinformatics analysis software, among others. Simultaneously, the company is actively expanding into overseas markets, having secured CE certification from the European Union for five of its products.
Our company operates globally